{"podcast":{"title":"Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology","slug":"weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980","podcast_index_feed_id":7345980,"rss_url":"https://anchor.fm/s/ff5a3958/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/amer-ghavanini","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/42741030/42741030-1735440401368-ad7d63bca66f6.jpg","author":"Amer Ghavanini","episode_count":207,"summary":"A selection of recent neurology papers is summarized and discussed, with a focus on review articles and those that have the potential to change clinical practice. Please note that AI has been used in generating the content.","last_synced_at":"2026-07-07T06:17:21.772797+00:00","page_url":"https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980"},"episode":{"title":"IV Fosphenytoin for Acute Trigeminal Neuralgia Exacerbations","slug":"iv-fosphenytoin-for-acute-trigeminal-neuralgia-exacerbations","published_at":"2026-06-21T20:11:56+00:00","page_url":"https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980/iv-fosphenytoin-for-acute-trigeminal-neuralgia-exacerbations","show_page_url":"https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980","url":"https://podcasters.spotify.com/pod/show/amer-ghavanini/episodes/IV-Fosphenytoin-for-Acute-Trigeminal-Neuralgia-Exacerbations-e3l3ea5","audio_url":"https://anchor.fm/s/ff5a3958/podcast/play/121796357/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-5-21%2F0a561b0c-5081-7d5f-c2b1-250fcfba2609.m4a","summary":"This source describes a phase 3 clinical trial investigating the effectiveness of intravenous fosphenytoin for treating sudden, intense flare-ups of trigeminal neuralgia . While standard oral medications often fail to provide immediate relief for this severe facial pain, the study found that injectable therapy significantly reduced pain levels within two hours compared to a placebo. Researchers also noted a substantial decrease in the frequency of attacks over a 24-hour period among those receiving the active drug. The trial results indicate that the treatment was well-tolerated , with only mild side effects like sleepiness and nausea reported by participants. Ultimately, the authors conclude that this medication offers a promising emergency intervention for patients in crisis, though larger studies are suggested to confirm these preliminary findings. This research provides high-level evidence for a fast-acting alternative to surgery or insufficient oral drugs.","meta_description":"This source describes a phase 3 clinical trial investigating the effectiveness of intravenous fosphenytoin for treating sudden, intense flare-ups of trige…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1075,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980/episodes/iv-fosphenytoin-for-acute-trigeminal-neuralgia-exacerbations/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980/iv-fosphenytoin-for-acute-trigeminal-neuralgia-exacerbations.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}